US2019009270A1PendingUtilityA1

Method of osteogenic differentiation in microfluidic tissue culture systems

Assignee: CEDARS SINAI MEDICAL CENTERPriority: Jan 12, 2016Filed: Sep 13, 2018Published: Jan 10, 2019
Est. expiryJan 12, 2036(~9.5 yrs left)· nominal 20-yr term from priority
A61K 51/02B01L 3/5085G01T 1/1644B01L 3/5027C12N 5/0696G01T 1/2985A61K 49/0019A61K 49/005C12N 5/0697C12N 5/0662C12N 5/0075C12M 41/40A61M 2205/3334A61L 27/3895C12N 5/0655C12N 5/0668G01N 33/5038C07K 14/78C12N 5/0654C12N 5/0663C12N 5/0062C12N 5/0619C12N 2501/727
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Microfluidic “organ-on-a-chip” devices have been developed with the aim to replicate human tissues in vitro. However, there is no option to quantitatively monitor biological processes that take place within the chip, over time. Destructive methods in order to analyze, tissue formation, gene expression, protein secretion etc. require the harvest of the “tissue” at a certain time point. Described herein are methods and compositions for non-destructive molecular imaging methods and systems in order to quantitatively monitor specific biological processes, over time, within the chip, without the need to harvest.

Claims

exact text as granted — not AI-modified
1 - 23 . (canceled) 
     
     
         24 . A method of culturing mesenchymal stem cells (MSCs) comprising flowing culture media over said MSCs in a microfluidic device to produce a higher number of proliferated MSCs in culture than in the absence of said flowing. 
     
     
         25 . The method of  claim 24 , wherein the microfluidic device comprises one or more channels. 
     
     
         26 . The method of  claim 24 , wherein the flow rate of said culture media is 30 ul per hour. 
     
     
         27 . The method of  claim 24 , wherein the microfluidic device comprises a membrane and said cells are attached to said membrane. 
     
     
         28 . The method of  claim 24 , wherein proliferation of the cells is monitored without disrupting the culture. 
     
     
         29 . The method of  claim 24 , wherein the cells are cultured for three weeks. 
     
     
         30 . The method of  claim 24 , further comprising,
 adding one or more labeling agents to the microfluidic device; and   detecting the labeling agent.   
     
     
         31 . The method of  claim 24 , further comprising,
 detecting one or more macromolecules secreted by the MSCs.   
     
     
         32 . A method of osteogenic differentiation comprising flowing osteogenic media over mesenchymal stem cells (MSCs) in an organ-on-a-chip device to produce a higher number of differentiated MSCs in culture that express osteocalcin and bone sialoprotein (bsp) osteogenic markers than in the absence of said flowing. 
     
     
         33 . The method of  claim 32 , wherein the microfluidic device comprises one or more channels. 
     
     
         34 . The method of  claim 32 , wherein the flow rate of said culture media is 30 ul per hour. 
     
     
         35 . The method of  claim 32 , wherein the microfluidic device comprises a membrane and said cells are attached to said membrane. 
     
     
         36 . The method of  claim 32 , wherein the cells are cultured for three weeks. 
     
     
         37 . The method of  claim 32 , further comprising,
 adding one or more labeling agents to the microfluidic device; and   detecting the labeling agent.

Join the waitlist — get patent alerts

Track US2019009270A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.